Actuate Therapeutics, Inc. (ACTU)

0.9812 -0.01 (-1.41%) USD  |  NASDAQ  |  Sep 18, 16:00
0.98 0.00 (0.00%) After-Hours: 07:00
More

Actuate Therapeutics EPS Diluted (Quarterly) : -0.2039 for June 30, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for ACTU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 -0.2039
March 31, 2026 -0.239
December 31, 2025 -0.1959
September 30, 2025 -0.2527
June 30, 2025 -0.3028
March 31, 2025 -0.324
December 31, 2024 -0.33
Date Value
September 30, 2024 -0.3057
June 30, 2024 -0.3365
March 31, 2024 -0.4341
December 31, 2023 -0.3983
September 30, 2023 -0.3245
June 30, 2023 -0.2828
March 31, 2023 -0.2758

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Anika Therapeutics, Inc. 0.2412
Savara, Inc. -0.1587
Vericel Corp. 0.0422

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -4.867M
Total Expenses (Quarterly) 4.867M
Enterprise Value 19.54M
Earnings Yield -90.86%
Normalized Earnings Yield -90.86